Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ulbrich HF"'
Publikováno v:
Laboratory Animals. 42:473-482
Summary Beagle dogs continue to be used in experimental studies and preclinical and clinical trials, many of which address the usage of anaesthesia. In order to reduce the number of animals, researchers tend to conduct several experiments on a single
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1f83e2ae31c97576aebbd7131ca4394
https://doi.org/10.1258/la.2007.06023e
https://doi.org/10.1258/la.2007.06023e
Autor:
Boyken J; From the Department of MR and CT Contrast Media Research (J.B., J.L., G.J., T.F., H.P.) and Research and Pre-Clinical Statistics Group (H.F.U.), Bayer, Müllerstraße 178, 13353 Berlin, Germany; Department of In Vivo/Radioanalytics (A.T.) and Department of Bioanalytics LC-MS 3 & MALDI (U.T.), Bayer, Wuppertal, Germany; Department of Neuropharmacology, QPS Austria, Grambach, Austria (J.N., M.P.); and External Corporate Employment Resources, Bayer U.S., Whippany, NJ (T.B.)., Lohrke J; From the Department of MR and CT Contrast Media Research (J.B., J.L., G.J., T.F., H.P.) and Research and Pre-Clinical Statistics Group (H.F.U.), Bayer, Müllerstraße 178, 13353 Berlin, Germany; Department of In Vivo/Radioanalytics (A.T.) and Department of Bioanalytics LC-MS 3 & MALDI (U.T.), Bayer, Wuppertal, Germany; Department of Neuropharmacology, QPS Austria, Grambach, Austria (J.N., M.P.); and External Corporate Employment Resources, Bayer U.S., Whippany, NJ (T.B.)., Treu A; From the Department of MR and CT Contrast Media Research (J.B., J.L., G.J., T.F., H.P.) and Research and Pre-Clinical Statistics Group (H.F.U.), Bayer, Müllerstraße 178, 13353 Berlin, Germany; Department of In Vivo/Radioanalytics (A.T.) and Department of Bioanalytics LC-MS 3 & MALDI (U.T.), Bayer, Wuppertal, Germany; Department of Neuropharmacology, QPS Austria, Grambach, Austria (J.N., M.P.); and External Corporate Employment Resources, Bayer U.S., Whippany, NJ (T.B.)., Neddens J; From the Department of MR and CT Contrast Media Research (J.B., J.L., G.J., T.F., H.P.) and Research and Pre-Clinical Statistics Group (H.F.U.), Bayer, Müllerstraße 178, 13353 Berlin, Germany; Department of In Vivo/Radioanalytics (A.T.) and Department of Bioanalytics LC-MS 3 & MALDI (U.T.), Bayer, Wuppertal, Germany; Department of Neuropharmacology, QPS Austria, Grambach, Austria (J.N., M.P.); and External Corporate Employment Resources, Bayer U.S., Whippany, NJ (T.B.)., Jost G; From the Department of MR and CT Contrast Media Research (J.B., J.L., G.J., T.F., H.P.) and Research and Pre-Clinical Statistics Group (H.F.U.), Bayer, Müllerstraße 178, 13353 Berlin, Germany; Department of In Vivo/Radioanalytics (A.T.) and Department of Bioanalytics LC-MS 3 & MALDI (U.T.), Bayer, Wuppertal, Germany; Department of Neuropharmacology, QPS Austria, Grambach, Austria (J.N., M.P.); and External Corporate Employment Resources, Bayer U.S., Whippany, NJ (T.B.)., Ulbrich HF; From the Department of MR and CT Contrast Media Research (J.B., J.L., G.J., T.F., H.P.) and Research and Pre-Clinical Statistics Group (H.F.U.), Bayer, Müllerstraße 178, 13353 Berlin, Germany; Department of In Vivo/Radioanalytics (A.T.) and Department of Bioanalytics LC-MS 3 & MALDI (U.T.), Bayer, Wuppertal, Germany; Department of Neuropharmacology, QPS Austria, Grambach, Austria (J.N., M.P.); and External Corporate Employment Resources, Bayer U.S., Whippany, NJ (T.B.)., Balzer T; From the Department of MR and CT Contrast Media Research (J.B., J.L., G.J., T.F., H.P.) and Research and Pre-Clinical Statistics Group (H.F.U.), Bayer, Müllerstraße 178, 13353 Berlin, Germany; Department of In Vivo/Radioanalytics (A.T.) and Department of Bioanalytics LC-MS 3 & MALDI (U.T.), Bayer, Wuppertal, Germany; Department of Neuropharmacology, QPS Austria, Grambach, Austria (J.N., M.P.); and External Corporate Employment Resources, Bayer U.S., Whippany, NJ (T.B.)., Frenzel T; From the Department of MR and CT Contrast Media Research (J.B., J.L., G.J., T.F., H.P.) and Research and Pre-Clinical Statistics Group (H.F.U.), Bayer, Müllerstraße 178, 13353 Berlin, Germany; Department of In Vivo/Radioanalytics (A.T.) and Department of Bioanalytics LC-MS 3 & MALDI (U.T.), Bayer, Wuppertal, Germany; Department of Neuropharmacology, QPS Austria, Grambach, Austria (J.N., M.P.); and External Corporate Employment Resources, Bayer U.S., Whippany, NJ (T.B.)., Prokesch M; From the Department of MR and CT Contrast Media Research (J.B., J.L., G.J., T.F., H.P.) and Research and Pre-Clinical Statistics Group (H.F.U.), Bayer, Müllerstraße 178, 13353 Berlin, Germany; Department of In Vivo/Radioanalytics (A.T.) and Department of Bioanalytics LC-MS 3 & MALDI (U.T.), Bayer, Wuppertal, Germany; Department of Neuropharmacology, QPS Austria, Grambach, Austria (J.N., M.P.); and External Corporate Employment Resources, Bayer U.S., Whippany, NJ (T.B.)., Thuss U; From the Department of MR and CT Contrast Media Research (J.B., J.L., G.J., T.F., H.P.) and Research and Pre-Clinical Statistics Group (H.F.U.), Bayer, Müllerstraße 178, 13353 Berlin, Germany; Department of In Vivo/Radioanalytics (A.T.) and Department of Bioanalytics LC-MS 3 & MALDI (U.T.), Bayer, Wuppertal, Germany; Department of Neuropharmacology, QPS Austria, Grambach, Austria (J.N., M.P.); and External Corporate Employment Resources, Bayer U.S., Whippany, NJ (T.B.)., Pietsch H; From the Department of MR and CT Contrast Media Research (J.B., J.L., G.J., T.F., H.P.) and Research and Pre-Clinical Statistics Group (H.F.U.), Bayer, Müllerstraße 178, 13353 Berlin, Germany; Department of In Vivo/Radioanalytics (A.T.) and Department of Bioanalytics LC-MS 3 & MALDI (U.T.), Bayer, Wuppertal, Germany; Department of Neuropharmacology, QPS Austria, Grambach, Austria (J.N., M.P.); and External Corporate Employment Resources, Bayer U.S., Whippany, NJ (T.B.).
Publikováno v:
Radiology [Radiology] 2024 Jan; Vol. 310 (1), pp. e231984.
Autor:
Otto C; TRG Oncology and Gynaecological Therapy, Bayer Pharma AG, Berlin, Germany., Ulbrich HF; Global Drug Discovery Statistics, Bayer Pharma AG, Berlin, Germany., Freiberg C; Department of Global Biologics, Bayer Pharma AG, Wuppertal, Germany.
Publikováno v:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2022 Feb; Vol. 10 (1), pp. e00916.
Publikováno v:
Investigative radiology [Invest Radiol] 2021 Jun 01; Vol. 56 (6), pp. 341-347.
Autor:
Church N; Bayer, Whippany, NJ, USA., Leong L; Bayer, West Coast Innovation Center, San Francisco, CA, USA., Katterle Y; Bayer, Berlin, Germany., Ulbrich HF; Bayer, Berlin, Germany., Noerenberg I; Bayer, Berlin, Germany., Kitchen S; Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK., Michaels LA; Bayer, Whippany, NJ, USA.
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2018 Sep; Vol. 24 (5), pp. 823-832. Date of Electronic Publication: 2018 Jul 08.
Autor:
Kaehler KC; aDepartment of Dermatology, University of Kiel, Kiel bBayer Pharma AG, Berlin, Germany., Politz O, Henderson D, Ulbrich HF, Hauschild A, Mund C, Egberts F
Publikováno v:
Melanoma research [Melanoma Res] 2015 Jun; Vol. 25 (3), pp. 225-31.
Autor:
Becker EM; Bayer Pharma AG, Cardiology Research, Wuppertal, Germany ; University Witten/Herdecke, Fakultät für Gesundheit, Witten, Germany., Stasch JP, Bechem M, Keldenich J, Klipp A, Schaefer K, Ulbrich HF, Truebel H
Publikováno v:
PloS one [PLoS One] 2013 Aug 28; Vol. 8 (8), pp. e73502. Date of Electronic Publication: 2013 Aug 28 (Print Publication: 2013).
Autor:
Otto C; Therapeutic Research Group Oncology and Gynecological Therapy;, Schkoldow J, Krahl E, Fuchs I, Ulbrich HF
Publikováno v:
Experimental and therapeutic medicine [Exp Ther Med] 2012 Mar; Vol. 3 (3), pp. 410-414. Date of Electronic Publication: 2011 Dec 20.
Autor:
Bert B; Institute of Pharmacology and Toxicology, School for Veterinary Medicine, Freie Universität Berlin, 14195 Berlin, Germany. bert.bettina@vetmed.fu-berlin.de, Hartje I, Voigt JP, Arndt G, Ulbrich HF, Fink H, Hauff P
Publikováno v:
Laboratory animals [Lab Anim] 2008 Oct; Vol. 42 (4), pp. 473-82. Date of Electronic Publication: 2008 Sep 09.
Autor:
Hoffmann J; Research Laboratories of Schering AG, Berlin, Germany. jens.hoffmann@schering.de, Bohlmann R, Heinrich N, Hofmeister H, Kroll J, Künzer H, Lichtner RB, Nishino Y, Parczyk K, Sauer G, Gieschen H, Ulbrich HF, Schneider MR
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2004 Feb 04; Vol. 96 (3), pp. 210-8.